Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12049911
[patent_doc_number] => 20170326254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'Efficient delivery of therapeutic molecules in vitro and in vivo'
[patent_app_type] => utility
[patent_app_number] => 15/518183
[patent_app_country] => US
[patent_app_date] => 2015-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 31030
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15518183
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/518183 | Efficient delivery of therapeutic molecules in vitro and in vivo | Oct 8, 2015 | Issued |
Array
(
[id] => 10735950
[patent_doc_number] => 20160082100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS'
[patent_app_type] => utility
[patent_app_number] => 14/866582
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 17538
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14866582
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/866582 | RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS | Sep 24, 2015 | Abandoned |
Array
(
[id] => 11046297
[patent_doc_number] => 20160243256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'NUCLEIC ACID-LIPOPOLYMER COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/866493
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11513
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14866493
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/866493 | Nucleic acid-lipopolymer compositions | Sep 24, 2015 | Issued |
Array
(
[id] => 12099367
[patent_doc_number] => 09856456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Delivery agent'
[patent_app_type] => utility
[patent_app_number] => 14/863539
[patent_app_country] => US
[patent_app_date] => 2015-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 8
[patent_no_of_words] => 6151
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14863539
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/863539 | Delivery agent | Sep 23, 2015 | Issued |
Array
(
[id] => 12099367
[patent_doc_number] => 09856456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Delivery agent'
[patent_app_type] => utility
[patent_app_number] => 14/863539
[patent_app_country] => US
[patent_app_date] => 2015-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 8
[patent_no_of_words] => 6151
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14863539
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/863539 | Delivery agent | Sep 23, 2015 | Issued |
Array
(
[id] => 12566724
[patent_doc_number] => 10017817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Skin activation by acceleration of PDGF-BB activity
[patent_app_type] => utility
[patent_app_number] => 14/857014
[patent_app_country] => US
[patent_app_date] => 2015-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4525
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14857014
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/857014 | Skin activation by acceleration of PDGF-BB activity | Sep 16, 2015 | Issued |
Array
(
[id] => 12306633
[patent_doc_number] => 09938577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Conjugated polymeric particle and method of making same
[patent_app_type] => utility
[patent_app_number] => 14/855705
[patent_app_country] => US
[patent_app_date] => 2015-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 10398
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14855705
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/855705 | Conjugated polymeric particle and method of making same | Sep 15, 2015 | Issued |
Array
(
[id] => 12212377
[patent_doc_number] => 09909176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Efficient deep sequencing and rapid genomic speciation of RNA viruses (vRNAseq)'
[patent_app_type] => utility
[patent_app_number] => 14/841981
[patent_app_country] => US
[patent_app_date] => 2015-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 10181
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14841981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/841981 | Efficient deep sequencing and rapid genomic speciation of RNA viruses (vRNAseq) | Aug 31, 2015 | Issued |
Array
(
[id] => 12255285
[patent_doc_number] => 09927426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Methods of treating diseases with human trophoblast stem cells'
[patent_app_type] => utility
[patent_app_number] => 14/840970
[patent_app_country] => US
[patent_app_date] => 2015-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 64
[patent_no_of_words] => 12718
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14840970
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/840970 | Methods of treating diseases with human trophoblast stem cells | Aug 30, 2015 | Issued |
Array
(
[id] => 13119475
[patent_doc_number] => 10078089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-18
[patent_title] => Compositions and methods for treating steroid resistant nephrotic syndrome and/or steroid sensitive nephrotic syndrome
[patent_app_type] => utility
[patent_app_number] => 14/838551
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9301
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838551
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/838551 | Compositions and methods for treating steroid resistant nephrotic syndrome and/or steroid sensitive nephrotic syndrome | Aug 27, 2015 | Issued |
Array
(
[id] => 15783061
[patent_doc_number] => 10625234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Method of fabricating cell arrays and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/839170
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2055
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14839170
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/839170 | Method of fabricating cell arrays and uses thereof | Aug 27, 2015 | Issued |
Array
(
[id] => 15783061
[patent_doc_number] => 10625234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Method of fabricating cell arrays and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/839170
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2055
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14839170
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/839170 | Method of fabricating cell arrays and uses thereof | Aug 27, 2015 | Issued |
Array
(
[id] => 15783061
[patent_doc_number] => 10625234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Method of fabricating cell arrays and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/839170
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2055
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14839170
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/839170 | Method of fabricating cell arrays and uses thereof | Aug 27, 2015 | Issued |
Array
(
[id] => 15783061
[patent_doc_number] => 10625234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Method of fabricating cell arrays and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/839170
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2055
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14839170
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/839170 | Method of fabricating cell arrays and uses thereof | Aug 27, 2015 | Issued |
Array
(
[id] => 11969932
[patent_doc_number] => 20170274086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'CATIONIC LIPID FOR NUCLEIC ACID DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/504239
[patent_app_country] => US
[patent_app_date] => 2015-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20576
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/504239 | Cationic lipid for nucleic acid delivery | Aug 6, 2015 | Issued |
Array
(
[id] => 11834645
[patent_doc_number] => 20170216363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'NANOPARTICLE MODIFICATION OF HUMAN ADIPOSE-DERIVED MESENCHYMAL STEM CELLS FOR TREATING BRAIN CANCER AND OTHER NEUROLOGICAL DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/500655
[patent_app_country] => US
[patent_app_date] => 2015-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 23779
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15500655
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/500655 | NANOPARTICLE MODIFICATION OF HUMAN ADIPOSE-DERIVED MESENCHYMAL STEM CELLS FOR TREATING BRAIN CANCER AND OTHER NEUROLOGICAL DISEASES | Aug 6, 2015 | Abandoned |
Array
(
[id] => 14360159
[patent_doc_number] => 10301367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Compositions and methods for treatment of muscular dystrophy
[patent_app_type] => utility
[patent_app_number] => 15/328833
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 32132
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328833
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328833 | Compositions and methods for treatment of muscular dystrophy | Jul 23, 2015 | Issued |
Array
(
[id] => 14243957
[patent_doc_number] => 10272161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => RNA for use in the treatment of ligament or tendon lesions
[patent_app_type] => utility
[patent_app_number] => 15/326332
[patent_app_country] => US
[patent_app_date] => 2015-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 24
[patent_no_of_words] => 18734
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326332
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326332 | RNA for use in the treatment of ligament or tendon lesions | Jul 15, 2015 | Issued |
Array
(
[id] => 14700177
[patent_doc_number] => 10377822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Immunologic effector cell of targeted CLD18A2, and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/326974
[patent_app_country] => US
[patent_app_date] => 2015-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8146
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326974
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326974 | Immunologic effector cell of targeted CLD18A2, and preparation method and use thereof | Jul 14, 2015 | Issued |
Array
(
[id] => 10656463
[patent_doc_number] => 20160002607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'Adeno-Associated-Virus Rep Sequences, Vectors and Viruses'
[patent_app_type] => utility
[patent_app_number] => 14/795214
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 32692
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795214
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/795214 | Adeno-associated-virus Rep sequences, vectors and viruses | Jul 8, 2015 | Issued |